stage iiia uterine corpus cancer ajcc v7
Showing 1 - 7 of 7
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Complications in Older Gynecologic Cancer Undergoing Surgery
Completed
- Endometrial Serous Adenocarcinoma
- +9 more
- Comprehensive Geriatric Assessment
- Questionnaire Administration
-
Birmingham, Alabama
- +392 more
Nov 23, 2021
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v7 Trial in
Active, not recruiting
- Endometrial Clear Cell Adenocarcinoma
- +8 more
- Carboplatin
- +5 more
-
Birmingham, Alabama
- +669 more
Sep 28, 2021
Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7 Trial in
Completed
- Recurrent Uterine Corpus Carcinoma
- +5 more
- Carboplatin
- +7 more
-
Birmingham, Alabama
- +649 more
Sep 28, 2021
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong
Completed
- Endometrial Adenocarcinoma
- +11 more
- Bevacizumab
- +4 more
-
Berkeley, California
- +40 more
Feb 15, 2018